Bárbara Ferraz BarbosaFrancisco Cézar Aquino de MoraesCamila Bordignon BarbosaPlínio Takashi Karubi Palavicini SantosIzael Pereira da SilvaBruno Araujo Alves da SilvaJamile Cristine Marques BarrosRommel Mário Rodríguez BurbanoNey Pereira Carneiro dos SantosMarianne Rodrigues Fernandes2026-03-222026-03-22202310.3390/jpm13101460https://doi.org/10.3390/jpm13101460https://andeanlibrary.org/handle/123456789/85601Citaciones: 25Our results support the use of setmelanotide in treating severe obesity.enMedicineMelanocortin 4 receptorInternal medicineObesityWeight lossAdverse effectMeta-analysisRandomized controlled trialGastroenterologyEfficacy and Safety of Setmelanotide, a Melanocortin-4 Receptor Agonist, for Obese Patients: A Systematic Review and Meta-Analysisreview